IDEAL Data Expands Gilead’s Livdelzi Evidence Into Lower-ALP PBC Population Scrip Pharma Intelligence 5d
Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population FiercePharma 6d
Gilead Sciences Reports Positive Results From Phase 3 Study Of Livdelzi For Biliary Cholangitis RTT News 6d
Gilead eyes PBC expansion for Livdelzi on positive one-year data Clinical Trials Arena 5d Livdelzi Biotech Pharma All sources
How is Gilead Sciences's stock performance compared to other healthcare stocks Barchart 6d Pharma Healthcare
FOSTER CITY powerhouse nabs first U.S. Hep d drug as bay area rivals race Hoodline 16:40 Wed, 27 May Biotech FDA Pharma All sources
STAT Plus: Lilly shares safety, tolerability data on its next-gen obesity drug STAT 1d Eli Lilly Pharma The Lancet
Early cancer detection: Iranian company develops genetic laboratory device Pars Today 3d Biotechnology Pharma Iran
Supreme court backs maker of generic heart drug in 'Skinny label' case Medpage Today 3d Pharma Health Crime
STAT Plus: Drug companies, patient groups urge FDA to pause commissioner’s voucher program STAT 3d FDA Pharma Health
A weight-loss drug that also controls sleep apnea and knee pain: Eli Lilly may have found one Mint 21h Eli Lilly Novo Nordisk Obesity
Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supply The Times of India 1d Central Asia Uzbekistan Biotech
Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena 3d The Lancet Novartis
Top 10 London Stock Exchange stocks to consider buying in 2026 for UK exposure International Business Times - AU Edition 2d London Stock Exchange Global Stock Markets
